Abstract
The effects of the optical isomers of verapamil were compared on intact and partially ischemic pig hearts as well as on vascular smooth muscle of rabbits and rats. In K+-depolarized strips of rabbit mesenteric artery, both isomers shifted calcium dose-response curves (tension development) in a qualitatively similar manner to the right, with threshold concentrations of 10–8 m (—)verapamil and 10–7 m (+)verapamil. In K+-depolarized rat aortic strips, the calcium antagonistic activity was quantified. (+)Verapamil was at least as potent as several other coronary drugs [(±)verapamil = 1]: perhexiline 0.02, prenylamine 0.05, fendiline 0.05, diltiazem 0.15, (±)verapamil 0.15, (-)verapamil 1.5. The optical isomers of D600 showed a considerably greater difference in calcium antagonistic potency (about a factor of 60) as compared to verapamil (factor of 10). In the pig heart, reversible and reproducible ischemia reactions were provoked by repeated occlusions (3 min) of a branch of the LAD followed by reperfusion for 15 min. In the tested range of 0.4–2.0 mg/kg i.V., (-I-)verapamil dose-dependently reduced ischemic ST elevations in four epicardial leads. At an intermediate dose of 1 mg/kg, (+Verapamil diminished ST-elevations by 32% (occlusion 11 min p.i.). Results not statistically different were obtained with 0.1 mg/kg (-)verapamil (28%) and 0.2 mg/kg (±)verapamil (40%). No qualitative differences between the isomers could be observed with regard to hemodynamic parameters with equieffective reduction of the ischemia reaction: slight decrease in heart rate; prolongation of PQ duration with only minimal and insignificant effect of (+)verapamil; decrease of systolic and diastolic blood pressure, left ventricular pressure, and LV dp/dt max . In contrast to optically active and racemic verapamil, nifedipine in a hypotensive dose (0.05 mg/kg i.v.) increased heart rate and diminished ischemic ST elevations only moderately (13%). The results obtained on vascular smooth muscle and ischemic pig heart clearly show that there are no remarkable qualitative differences between verapamil enantiomers. It can be concluded that (+)verapamil, by its calcium antagonistic properties, contributes to the therapeutic efficacy of the racemic drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bayer, R., Kalusche, D., Kaufmann, R., and Mannhold, R. 1975. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. III. Effects of the optical isomers on transmembrane action potentials. Naunyn Schmiedebergs Arch. Pharmacol.290:81–97.
Bayer, R., Kaufmann, R., and Mannhold, R. 1975. Inotropic and electrophysiological actions of verapamil and D 600 in mammalian myocardium. II. Pattern of inotropic effects of the optical isomers. Naunyn Schmiedebergs Arch. Pharmacol.290:69–80.
Chiba, S., Kobayashi, M., and Furukawa, Y. 1978. Effects of optical isomers of verapamil on SA nodal pacemaker activity and contractility of the isolated dog heart. Jpn. Heart J.19:409–414.
Fleckenstein, A. 1971. Specific inhibitors and promoters of calcium action in the excitation-contraction coupling of heart muscle and their role in the prevention or production of myocardial lesions. In: P. Harris and L. Opie (eds.), Calcium and the Heart, pp. 135–188. Academic Press, New York.
Kaumann, A. J., and Serur, J. R. 1975. Optical isomers of verapamil on canine heart. Prevention of ventricular fibrillation induced by coronary artery occlusion, impaired atrioventricular conductance and negative inotropic and chronotropic effects. Naunyn Schmiedebergs Arch. Pharmacol.291:347–358.
Ludwig, C, and Nawrath, H. 1977. Effects of D 600 and its optical isomers on force of contraction in cat papillary muscles and guinea-pig articles. Br. J. Pharmacol.59:411–417.
Nawrath, H., Blei, J., Gegner, R., Ludwig, C, and Zong, X. 1981. No stereospecific effects of the optical isomers of verapamil and D-600 on the heart. In: A. Zanchetti and D. M. Krikler (eds.), Calcium Antagonism in Cardiovascular Therapy, Experience with Verapamil. Internat. Symposium, Florence. 2nd-4th October, 1980, pp. 52–63, Excerpta Medica, Amsterdam-Oxford-Princeton.
Nayler, W. G., Mas-Oliva, J., and Williams, A. J. 1980. Cardiovascular receptors and calcium. Circ. Res.46(Suppl. 1): 161–166.
Raschack, M., and Engelmann, K. 1980. Calcium-antagonistic activity and myocardial ischemia protection by both stereoisomers of verapamil. J. Mol. Cell. Cardiol.12(Suppl. 1):132.
Satoh, K., Yanagisawa, T., and Taira, N. 1979. Effects of atrioventricular conduction and blood flow of enantiomers of verapamil and of tetrodotoxin injected into the posterior and the anterior septal artery of the atrioventricular node preparation of the dog. Naunyn Schmiedebergs Arch. Pharmacol.308:89–98.
Satoh, K., Yanagisawa, T., and Taira, N. 1980. Coronary vasodilator and cardiac effects of optical isomers of Verapamil in the dog. J. Cardiovasc. Pharmacol.2:309–318.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Raschack, M., Engelmann, K. (1983). Calcium Antagonistic Activity and Myocardial Ischemic Protection by Both Stereoisomers of Verapamil. In: Chazov, E., Saks, V., Rona, G. (eds) Advances in Myocardiology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-4441-5_48
Download citation
DOI: https://doi.org/10.1007/978-1-4757-4441-5_48
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-4443-9
Online ISBN: 978-1-4757-4441-5
eBook Packages: Springer Book Archive